Direktorat Registrasi ObatValid

SUCRALFATE

Claim this product
BPOM Number
GKL2508522433A1
Approved
27 December 2025
Expiry
26 December 2030
Form
Suspension

About This Registration

SUCRALFATE is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL2508522433A1. Its current registration status is Valid, with the licence valid until 26 December 2030. The product is registered to HEXPHARM JAYA LABORATORIES - INDONESIA. BPOM first approved this registration in December 2025. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration Details

Application
newaero
Packaging
DUS, 1 BOTOL PLASTIK @ 100 ML
Department
Direktorat Registrasi Obat

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available
Custom questionnaires
Professional shoppers
Detailed reporting
Starting from $50 per city
What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

Ingredients (1)

SUCRALFATE SUSPENSION

Market Intelligence

Owner Portfolio
HEXPHARM JAYA LABORATORIES - INDONESIA holds 155 BPOM registrations
Manufacturer Scale
HEXPHARM JAYA LABORATORIES - INDONESIA produces 155 registered products
Registration Age
Registered for 6 months

FDA Cross-Reference

via openFDA
Generic Name
SUCRALFATE
Product Type
HUMAN PRESCRIPTION DRUG
Route of Administration
ORAL

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?

Claim it to manage registration, track renewals, and get expiry alerts.

Claim Product

More products from HEXPHARM JAYA LABORATORIES - INDONESIA

FLUOXETINE HYDROCHLORIDE

-GKL2608522601B1
Valid
Approved: May 24, 2026KAPSUL
View product →

FLUOXETINE HYDROCHLORIDE

-GKL2608522601A1
Valid
Approved: May 24, 2026KAPSUL
View product →

CIPROFLOXACIN LACTATE

-GKL0808515349A2
Valid
Approved: Jun 24, 2026INFUS
View product →

SUCRALFATE

-GKL2508522433A1
Valid
Approved: Dec 26, 2025SUSPENSI
View product →

METHYLPREDNISOLONE

-GKL2508512310C1
Valid
Approved: Dec 26, 2025TABLET
View product →

Products in the same class

MELASKIN-TF

-DKL2129001829A1
Valid
Approved: Mar 11, 2026KRIM
ROI SURYA PRIMA FARMA - INDONESIA
View product →

CHOLESTOR

-DKL1634604317B1
Valid
Approved: Nov 29, 2025TABLET SALUT SELAPUT
FERRON PAR PHARMACEUTICALS
View product →

CEFEPIME HCL MONOHYDRATE

-GKL1140300544A1
Valid
Approved: Sep 30, 2025SERBUK INJEKSI
NATURA LABORATORIA PRIMA - INDONESIA
View product →

ZOLACAP

-DKL1732406744A1
Valid
Approved: Sep 3, 2025SERBUK INJEKSI
CAPRIFARMINDO LABORATORIES - INDONESIA
View product →

PAXOMED

-DKI1435500243A1
Valid
Approved: Aug 29, 2025INJEKSI
MEGA LIFESCIENCES INDONESIA
View product →
1